TREM2 and central nervous system cancer: High expression (more than 25% of positive-stained tumor cells), low expression (less than 25% of positive-stained tumor cells) and non-expression of TREM2 was observed in 41, 23 and 6 cases of glioma, respectively (Figure 1C).